Methods for treatment of attention deficit hyperactivity disorder

作者: Feng Zhang , David Lickrish

DOI:

关键词:

摘要: Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or hyperactivity (ADHD) include dosage forms that deliver a therapeutic amount active drug in delayed controlled release formulation. The form can be administered at night is from 4 to 6 hours longer, followed by an ascending rate.

参考文章(155)
Paul Hodgkins, Richard Couch, Alex Michaels, Enantiomeric amphetamine compositions ,(2004)
Xui Xui Cheng, Guohua Zhang, Xiaohong Qi, Manesh Dixit, Diltiazem controlled release formulation and method of manufacture ,(2006)
Theophilus Jones Gana, Kenneth Stephen Albert, Paul J. Maes, Chronotherapeutic diltiazem formulations and the administration thereof ,(2003)
Robert Francis Kaiko, Benjamin Oshlack, John Joseph Minogue, Mark Chasin, Controlled release oxycodone compositions ,(1992)
Niall Fanning, Paul Stark, Catherine Mary Kelly, Multiparticulate bisoprolol formulation ,(2000)
Shinji Narisawa, Minako Nagata, Yoshiyuki Hirakawa, Masao Kobayashi, Hiroyuki Yoshino, An organic acid‐induced sigmoidal release system for oral controlled‐release preparations. 2. Permeability enhancement of eudragit RS coating led by the physicochemical interactions with organic acid Journal of Pharmaceutical Sciences. ,vol. 85, pp. 184- 188 ,(1996) , 10.1021/JS950180O
Samuel R. Saks, Suneel K. Gupta, Carol A. Christopher, Lawrence G. Hamel, Diane R. Guinta, Methods and devices for providing prolonged drug therapy ,(2013)